ARCT
Arcturus Therapeutics Holdings Inc.
Key Financials
Net Income
$-65783000
↑ 18.7%
Operating Income
$-76260000
↑ 20.3%
Revenue
$82.0M
↓ 46.1%
Total Liabilities
$57.2M
↓ 44.6%
Shareholders' Equity
$214.0M
↓ 11.2%
Total Assets
$271.1M
↓ 21.2%
EPS (Diluted)
$-2.40
↑ 20.0%
Cash & Equivalents
$230.9M
↓ 2.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 10-K | 3/3/2026 | View on SEC |
| 8-K | 3/3/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
| SCHEDULE 13G/A | 2/3/2026 | View on SEC |
| SCHEDULE 13G/A | 1/8/2026 | View on SEC |
| S-3 | 12/30/2025 | View on SEC |
| 4 | 12/19/2025 | View on SEC |
| 4 | 12/19/2025 | View on SEC |
| 4 | 12/19/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ARCT |
| Company Name | Arcturus Therapeutics Holdings Inc. |
| CIK | 1768224 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8589002660 |